AZO
53
3
DHR
47
-3
QRVO
43
3
HAL
50
2
PYPL
52
7
EA
31
-3
WM
73
2
STI
19
12
TJX
50
2
ROK
46
2
NAVI
63
8
V
62
10
DRI
48
3
CNX
56
4
EIX
67
5
FLS
69
5
R
66
3
ETN
78
2
IRM
75
2
NWS
47
2
AZO
53
3
DHR
47
-3
QRVO
43
3
HAL
50
2
PYPL
52
7
EA
31
-3
WM
73
2
STI
19
12
TJX
50
2
ROK
46
2
NAVI
63
8
V
62
10
DRI
48
3
CNX
56
4
EIX
67
5
FLS
69
5
R
66
3
ETN
78
2
IRM
75
2
NWS
47
2
Financhill
Back

Nippon Telegraph & Telephone Vs. Kymera Therapeutics Industry Stock Comparison

Sell
47

NTTYY
Nippon Telegraph & Telephone

Last Price:
24.73
Seasonality Move:
0.51%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
47
Nippon Telegraph & Telephone (NTTYY) is a Sell

Is Nippon Telegraph & Telephone a Buy, Sell or Hold?

  • The current Nippon Telegraph & Telephone [NTTYY] share price is $24.73. The Score for NTTYY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • NTTYY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTTYY Stock Price Chart

What is Nippon Telegraph & Telephone's stock price today?

  • The Nippon Telegraph & Telephone share price today is $24.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTTYY is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTTYY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 34.9 Sell
Chaikin Money Flow: -133615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.95 - 26.19) Sell
Bollinger Bands (100): (24.11 - 26.27) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

NTTYY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.85 Sell
20-day SMA: 25.39 Sell
50-day SMA: 25.85 Sell
200-day SMA: 27.25 Sell
8-day EMA: 24.86 Sell
20-day EMA: 25.28 Sell
50-day EMA: 25.59 Sell
200-day EMA: 26.67 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Nippon Telegraph & Telephone Earnings Growth & NTTYY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Nippon Telegraph & Telephone Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):